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Nanoparticle research is currently an area of intense scientific research due to variety of potential ap-
plications in optics, electronics, biotechnology, health care, biomedical, chemical, and pharmaceutical 
fields. The physical sizes of these materials create a strong possibility for their interaction with biological 
systems. Biological systems themselves contain various components that have nanometer dimensions (pro-
teins, nucleic acids, membranes), therefore nanopaticles can be useful both for in vivo and in vitro biologi-
cal researches and applications. Among the metallic nanoparticles (NPs), the most important materials in 
nanomedicine are gold, silver, copper, iron, cobalt, nickel, platinum, magnesium, palladium and rhodium.  
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1. INTRODUCTION 
 
The application of nanomaterials in biomedicine 
has led to the development of diagnostic devices, 
contrast agents, analytical tools, physical therapy 
applications, and drug delivery vehicles. In all the 
nanomaterials with antibacterial properties, metallic 
nanoparticles are the best. Nanoparticles of Cu, Co, 
Ni, Ag have shown catalytical properties and they are 
used in synthesis of various pigments. Copper 
nanoparticles can significantly increase bone density, 
increase binding strength, and improving 
organisational forms, and are significant in 
osteoporosis prevention and treatment. Nanoscale 
magnetic particles are playing increasingly important 
role as tools in biotechnology and medicine, as well as 
for studding biological systems. These biomedical 
applications of magnetic nanoparticles include target 
drug delivery as magnetic vectors can be directed to 
the target of interest using either external or internal 
magnetic field, magnetic contrast agents in magnetic 
resonance imaging (MRI), hyperthermia agents for 
localized damage of the tumor tissue using high 
frequency magnetic field, and cell and biomolecule 
separation. Composites comprising the calcium phos-
phates and natural biopolymers are widely used in the 
manufacturing of orthopaedic biomaterials. The hy-
droxyapatite is used as a component of synthetic ma-
terials for orthopaedy and stomatology for a long time. 
 
2. METAL NANOPARTICLES 
 
Main areas of nanoparticles applications need 
controllable fabrication of nanostructures with a high 
degree of regularity and uniformity in order to control 
their properties precisely. Thus, it’s very important to 
develop technology for efficient formation of ordered 
arrays of nanoparticles on substrate surface with tun-
able forms, size and distance between structural ele-
ments. There are different methods of NPs obtaining, 
most often they are grown by wet-chemical methods 
through reduction of their salts. In this work a 
bottom-up magnetron sputtering method under 
conditions close to thermodynamic equilibrium is used 
for obtaining NPs of Cu, Ni, Ti, Cr and Al.  
Characteristic peculiarities of quiasi-equilibrium 
conditions are: the condensation process occurs at 
sufficiently low supersaturation to provide a 
proximity to phase equilibrium between condensate 
and depositing substance; this supersaturation 
remains stable in the course of the time to guarantee 
steady-state conditions of the condensation process. 
Self-assembling of metal nanosystems was 
performed in technological setup equipped with three 
direct current magnetron sputterers.  One of them 
was used for sputtering of depositing material. As a 
working gas argon was used at pressure more then 10 
Pa. Argon was subjected to deep purification via the 
absorption of chemically active gases during the 
process of additional Ti sputtering by two lateral 
magnetrons. The partial pressure of the chemically 
active residual gases (mainly O2, H2 and N2) was 
8∙10 – 8 Pa. Fresh KCl cleavages were used as the 
substrates. The reduction of the free path length at 
the increased working gas pressures allowed us to 
average the energy of the ion-sputtered atoms, as well 
as to ensure the equiprobable arrival of the substance 
onto different facets of the growing crystals near the 
growth surface.  
Approaching to equilibrium was achieved by 
heating of the growth surface under the plasma 
action. In this case, the average energy of the ion-
sputtered atoms is one order of magnitude higher 
than the energy of thermally evaporated atoms and is 
equal to about 5 – 8 eV, which corresponds to a 
particle temperature of  38000 K. Moreover, it is 
known that the incomplete thermal accommodation 
needs the energy of condensed atoms corresponding to 
a temperature above 6000 K. Hence, the incomplete 
thermal accommodation enhances the reevaporation 
of adatoms and, thus, makes it possible to achieve 
near-equilibrium conditions at relatively low 
substrate temperatures.  
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We have established that modern conventional 
notions of the metal condensation mechanism under 
Volmer–Weber conditions are limited only by 
sufficiently high supersaturations and that the cluster 
nanosystems can be formed under the conditions 
closest to the equilibrium ones. In this case, the near-
equilibrium condensation and the Ostwald ripening, 
which are maintained by the effect of the particles on 
the growth surface, are the necessary prerequisites of 
the self-organization of the statistical uniformity of 
nanosystems.  
 
3. CHITOSAN/HYDROXYAPATITE SCAFFOLDS 
 
It is well known that bone tissue of human and 
animals is made of protein matrix individual for each 
living organism and mineral component which is 
inorganic compound of calcium and phosphor, in other 
words hydroxyapatite (HP). That is why different 
implants produced on the basis of HP  are widely used in 
orthopaedics and traumatology.  Thus, creation of new 
artificial materials on the basis of HP with advanced 
properties and characteristics close to human bone 
tissue are of great interest to scientists. It is worth 
noting, that artificial HP implants have very high 
biocompatibility. Composite nanostructured materials 
made of natural biopolymers and hydrogel nanoreactor 
matrixes have much more better mechanical properties 
than pure HP and strength of the nanocomposite can be 
comparable with natural bone. 
Nanocomposites comprising calcium phosphates 
and natural biopolymers are widely used as 
biomaterials for bone tissue repair and engineering. 
Chitosan/hydroxyapatite scaffolds could be used for 
bone regeneration in case the application of auto- or 
allografts is impossible. There are several ways to 
produce such composite materials. Most of them 
involve two major stages: first, the synthesis of an 
organic polymeric scaffold of pure or chemically treated 
and modified chitosan and, second, mineralization of 
the scaffold in simulated body fluid (the biomimetic 
way) or in saturated matrix solutions.  
The objective of this work was to characterize and 
study in vivo biodegradation of simple 
chitosan/hydroxyapatite scaffolds that were obtained in 
aqueous medium from chitosan solution and soluble 
precursor salts by a one step coprecipitation method. A 
study of in vivo behavior of the materials was then 
performed using model linear rats. For these 
experiments 48 linear laboratory rats at the age of 4 
months were used. The Ukrainian National Act of 
animal protection against cruel treatment (Act No 
3447-IV 21.02.2006) regulating the care and use of 
laboratory animals has been observed. At the middle 
one-third of right tibia of the animals perforated defects 
were made with a stomatological borer, diameter 2 mm, 
in the sterile operating room. The width of a tibial 
diaphysis of adult rats is at the average from 4.2 to 
4.7 mm. When a perforating bone defect is modeled, it 
is necessary to preserve integrity of bone, which causes 
the intramembranous type of bone regeneration. 
A model defect in this case cannot be wider than 
2 mm. The 50/50 chitosan-hydroxyapatite scaffolds 
were chosen for in vivo evaluation. In the experimental 
group of animals cylindrical ChAp rods were implanted 
into traumas, diameter of the rods was equal to the 
width of the wound channel. The control group was 
comprised of the rats with the analogous tibial defects, 
which were not filled with the investigated material. 
The animals were taken out of the experiment after 5, 
10, 15, and 24 days after implantation and  histological 
and histo-morphometric analyses of decalcified 
specimens were performed to evaluate the stages of 
biodegradation processes. Calcified specimens were 
examined by scanning electron microscopy with X-ray 
microanalysis to compare elemental composition and 
morphological characteristics of the implant and the 
bone during integration. To obtain porous materials, a 
lyophilization procedure was applied to wet (not dried 
completely) substances by using the vacuum chamber 
VUP-5M in which a glass sample-holder cooled with 
liquid nitrogen had been mounted. The frozen samples 
were dried under 10 – 3 Pa overnight. Porous 
chitosan/hydroxyapatite scaffolds have shown 
osteoconductive properties and have been replaced in 
the in vivo experiments by newly formed bone tissue.  
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